Who Paid My Doc
Synovasure Alpha Defensin
Device Hips
PDI 00887868358852
General payments
$38,717
Research payments
$603,070
Through program year 2025, $38,717 in general payments and $603,070 in research payments were reported against Synovasure Alpha Defensin (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $25,156 | 35 |
| 2025 | Research | $285,704 | 15 |
| 2024 | General | $12,930 | 83 |
| 2024 | Research | $175,541 | 16 |
| 2023 | General | $243 | 6 |
| 2023 | Research | $141,825 | 4 |
| 2022 | General | $388 | 6 |
Breakdown
The top 5 of 22 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
130 general · 35 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.